Effect of sleep deprivation on insulin sensitivity and cortisol concentration in healthy subjects

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 13, Issue 2, 2000, Pages 80-83

  González Ortiz, Manuel ^a,b   Martinez Abundis E ^a   Balcazar Munoz B R ^a   Pascoe Gonzalez S ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Colonia Independencia ^*  (Mexico)

Author keywords

Cortisol level; Insulin sensitivity; Sleep deprivation; Wakefulness

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCORTISONE; INSULIN; OCTREOTIDE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; INSULIN SENSITIVITY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SLEEP; SLEEP DEPRIVATION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; CREATININE; FEMALE; HUMANS; HYDROCORTISONE; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; SINGLE-BLIND METHOD; SLEEP DEPRIVATION; URIC ACID;

EID: 0343674487     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Bell P.M.: Clinical significance of insulin resistance. Diabet. Med. 13: 504-509, 1996.
2. Nestler J.E.: Assessment of insulin resistance. Sci. Am. 271: 58-67, 1994.
3. Czeisler C.A., Johnson M.P., Duffy J.F., Brown E.N., Ronda J.M., Kronauer R.E.: Exposure to bright light and darkness to treat physiologic maladaptation to night work. N. Engl. J. Med. 322: 1253-1259, 1990.
4. Pei D., Jones C.N.O., Bhargava R., Chen Y.D.I., Reaven G.M.: Evaluation of octreotide to assess insulin-mediated glucose disposal by the insulin suppression test (letter). Diabetologia 37: 843-844, 1994.
5. Van Helder T., Radomski M.W.: Sleep deprivation and the effect on exercise performance. Sports Med. 7:435-447, 1989.
6. Van Cauter E., Blackman J.D., Roland D., Spire J.P., Refetoff S., Polonsky K.S.: Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep. J. Clin. Invest. 88: 934-942, 1991.
7. Van Cauter E., Shapiro E.T., Tillil H., Polonsky K.S.: Circadian modulation of glucose and insulin responses to meals: relationship to cortisol rhythm. Am. J. Physiol. 262: E467-475, 1992.
8. Lee A., Ader M., Bray G.A., Bergman R.N.: Diurnal variation in glucose tolerance. Cyclic suppression of insulin action and insulin secretion in normal-weight, but not obese, subjects. Diabetes 41: 750-758, 1992.
9. Porter J.P.: Effect of intrahypothalamic insulin on sympathetic nervous function in rats drinking a high-sucrose solution. Am. J. Physiol. 266: R1463-1469, 1994.
10. Van Cauter E., Polonsky K.S., Blackman J.D., Roland D., Sturis J., Byrne M.M., Scheen A.J.: Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity. J. Clin. Endocrinol. Metab. 79: 1797-1805, 1994.
11. Shankar R., Zhu J.S., Ladd B., Henry D., Shen H.Q., Baron A.D.: Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action. J. Clin. Invest. 102: 1403-1412, 1998.
12. Caro J.F., Sinha M.K, Kolaczynski J.W., Zhang P.L., Considine R.V.: Leptin: the tale of an obesity gene. Diabetes 45: 1455-1462, 1996.
13. Boden G., Chen X., Urbain J.L.: Evidence for a circadian rhythm of insulin sensitivity in patients with NIDDM caused by cyclic changes in hepatic glucose production. Diabetes 45: 1044-1050, 1996.